Implementation Manager

AI meets DNA: Benchling and Anthropic to revolutionize biotech. Benchling and Anthropic are teaming up to bring Claude AI into biotech labs, fusing biology with intelligence to supercharge research and discovery. The biotechnology industry, driven by complex data and iterative experimentation, is undergoing a transformative shift with the integration of artificial intelligence. Benchling, a leading San Francisco-based life sciences R&D platform, announced a groundbreaking partnership with Anthropic, the creators of the Claude AI models. This collaboration embeds Claude's advanced reasoning capabilities directly into Benchling's cloud-based ecosystem via Amazon Bedrock, enabling scientists to streamline research processes with natural language interactions. This partnership marks a significant step toward accelerating scientific discovery while maintaining stringent data security standards, addressing the needs of researchers in pharmaceuticals, genomics, and beyond. The life sciences sector is no stranger to AI's potential. Recent data indicates that 43% of organizations in this field have reached transformational AI adoption, outpacing the cross-industry average of 35%. However, only one in five attributes significant financial gains to AI, highlighting the need for practical, domain-specific integrations. By combining Benchling's biology-focused platform with Anthropic's secure and interpretable AI, this alliance aims to deliver measurable efficiency and innovation to research teams worldwide. Benchling: empowering biotech through collaboration and data. Since its founding in 2012 by MIT graduates, Benchling has become a cornerstone for over 200,000 scientists across more than 1,000 global organizations, including industry giants like Regeneron and Genentech. With a valuation of $6.1 billion and a workforce of approximately 800, the company, led by CEO Sajith Wickramasekara since 2023, focuses on streamlining biotechnology workflows. Its cloud-native platform supports the entire R&D lifecycle - experiment design, data management, regulatory compliance, and manufacturing scale-up - through intuitive tools that prioritize collaboration and standardization. Benchling's commitment to AI integration was evident at its Benchtalk 2025 conference in Boston, where it unveiled Benchling AI. This suite enhances antibody discovery, automates data analysis, and optimizes workflows, addressing the 40% of scientists' time often lost to administrative tasks. Strategic acquisitions in August 2025, including ReSync Bio and Sphinx Bio, further bolstered its AI capabilities for molecular design and experimental planning. As Wickramasekara stated, "We're building tools that let scientists focus on discovery, not paperwork." This human-centric approach ensures that technology amplifies creativity and teamwork in labs. Anthropic's Claude: A trusted AI for scientific precision. Anthropic's Claude models excel in advanced reasoning and natural language processing, making them ideal for complex scientific tasks. Anthropic's Constitutional AI framework embeds ethical guidelines to minimize biases and errors, a critical feature for regulated industries like pharmaceuticals. The company's focus on life sciences is deliberate. Its AI for Science Program, launched in May 2025, supports researchers in hypothesis generation and data analysis. A webinar series, "Claude for Life Sciences," showcased real-world applications, such as Novo Nordisk's use of Claude to draft clinical study reports, streamlining documentation processes. Through partnerships with AWS and Snorkel AI, Anthropic has enabled biotech firms to extract insights from unstructured data, enhancing analytics and driving revenue growth. As Amodei noted, "Our goal is to empower scientists with AI that's both powerful and trustworthy." Claude's ability to process scientific terminology with precision sets it apart. From interpreting genomic sequences to optimizing experimental protocols, it delivers reliable outputs that align with the rigorous demands of biotech research. This capability makes Claude a natural fit for Benchling's data-rich environment, where accuracy and context are paramount. The partnership in action: ai-powered research at scale. The Benchling-Anthropic collaboration integrates Claude models into Benchling's platform via Amazon Bedrock, enabling seamless natural language interactions within existing workflows. This integration leverages Claude's most advanced models, to process both structured data, like assay results, and unstructured data, such as lab notes. * Data Analysis and Reporting: Claude generates concise summaries of complex datasets, such as genomic variations or clinical trial outcomes, enabling faster decision-making. * Workflow Automation: AI agents automate repetitive tasks like protocol creation for cell therapies, reducing manual effort and enhancing reproducibility. * Collaborative Insights: Real-time querying integrates with external tools like PubMed, fostering team-based problem-solving and enriched data context. Wickramasekara emphasized the impact: "This partnership brings AI directly to the scientist's workbench, accelerating innovation while upholding data integrity." Early pilots, including an expanded collaboration with Moderna in May 2025, demonstrate tangible benefits, such as a 50% reduction in documentation time and improved error detection. Real-World impact: from genomics to clinical trials. This integration delivers practical value across biotechnology workflows. In genomic research, Claude analyzes sequencing data to identify disease markers, supporting precision medicine initiatives like oncology drug development. For cell therapy, it automates protocol design, ensuring consistency in treatments like CAR-T, which require exacting standards for scalability. In clinical trials, Claude's ability to summarize voluminous reports into actionable insights streamlines regulatory processes. Benchling's AI agents transcribe experimental logs and flag discrepancies, reducing review times significantly. In sustainable biomanufacturing, Claude optimizes yield predictions by analyzing molecular interactions, supporting greener production methods. These applications align with industry projections that AI could generate $350-410 billion annually for pharmaceuticals by accelerating drug development. Security and compliance: A foundation for trust. Data security is a cornerstone of this partnership. Benchling adheres to HIPAA and GDPR standards, while Anthropic's Claude operates within Amazon Bedrock's secure environment, preventing data leakage. Features like access controls and audit logs safeguard intellectual property, addressing concerns raised in Anthropic's September 2025 biorisk report. As regulatory demands for AI transparency grow, particularly in clinical trials, this partnership's focus on reliability positions it as a leader in compliant AI adoption. The future of AI in Life Sciences. Looking ahead, this collaboration sets a precedent for AI-driven research. Benchling plans to expand Claude's customization options, allowing users to tailor AI tools to specific workflows. Ongoing partnerships, such as with Moderna, explore new frontiers in drug discovery, while Anthropic's AI for Science Program democratizes access to these capabilities. By 2026, as AI maturity deepens, such integrations will likely become standard, driving solutions for global health challenges. By embedding AI thoughtfully into scientific workflows, Benchling and Anthropic are paving the way for a future where innovation is faster, safer, and more impactful.

Benchling partners with Anthropic to build a bridge between science and AI. Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ - Benchling today announced a partnership with Anthropic, an AI safety and research company and the creator of Claude, to advance AI in biotech through the Claude for Life Sciences Ecosystem. The collaboration pairs Benchling's trusted data foundation and AI agents with Claude's advanced reasoning capabilities. Scientists can now ask Claude questions about their Benchling data to get clear, source-linked answers, summaries, and decision-ready reports in minutes. Benchling AI agents in Claude handle the heavy-lifting of searching structured data like assay results and molecules and pulling unstructured context buried in lab notebooks, so scientists can focus on analysis and decisions. jwplayer.key="3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=" How scientists are using Benchling AI in Claude today. jwplayer('myplayer1').setup({file: 'https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4', image: 'https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4?p=thumbnail', autostart:'false', stretching: 'uniform', width: '512', height: '288'}); AI's potential for impact in life sciences is profound. As Anthropic CEO Dario Amodei has said in his Machines of Loving Grace essay, AI could "compress decades of biological progress into just a few years," opening the door to far better prevention and treatment across diseases. Getting there requires operationalizing AI: pairing advanced models with trustworthy, secure data; purpose-built workflows; and access for every scientist. "AI in R&D only works through an ecosystem. Anthropic is doing this right, bringing together the best technologies while putting access, governance, and interoperability first," said Ashu Singhal, Co-founder and President of Benchling. "Benchling is uniquely positioned to contribute. For more than a decade, scientists have trusted us as the source of truth for experimental data and to modernize their workflows. Now we're building AI that powers this next chapter of R&D." "We're connecting Claude to the systems science already runs on. With Benchling's trusted data foundation and AI workflows, Claude helps teams move from research questions to results faster, at lab, program, and portfolio scale," said Eric Kauderer-Abrams, Head of Life Sciences and Biology, Anthropic. Claude for Life Sciences leverages Benchling as the system of record while Claude synthesizes insights across the data. The integration between Claude and Benchling is possible via Model Context Protocol (MCP), and enables users to move seamlessly between the two, with one-click traceability to the underlying scientific data. Existing permissions and audit logs carry over automatically, so organizations can roll out AI across R&D while maintaining control and compliance. Here's how researchers, program leads, bioinformaticians, and scientists are using Benchling in Claude. | Category | Example prompt | | Recommendations"Based on our last three in vivo results in Benchling and recent FDA guidance, what should we test next?" | | Portfolio insights"Aggregate results from our top five programs and highlight which ones are showing the strongest early efficacy signals compared with industry benchmarks." | | Workflow orchestration"Pull my Benchling assay results and check for related compound data to see if we've already profiled these molecules." | | Cross-source comparison"Compare the IC50 results from my last two Benchling experiments with recent PubMed articles on AAV stability." | | Multi-tool reporting"Draft a report that combines Benchling notebook data with statistical analyses to create a single study summary." | Benchling's AI agents in the Claude for Life Sciences ecosystem are available to Benchling customers with Benchling AI enabled. Customers should reach out to their account teams for set-up and more information. About Benchling Benchling's mission is to unlock the power of biotechnology. Founded in 2012, Benchling provides a unified, cloud-based platform trusted by more than 1,300 biotech companies worldwide, from pioneering startups to global biopharmas like Merck, Moderna, and Sanofi. Benchling's products help scientists capture, connect, and analyze data across the R&D lifecycle. With Benchling AI, scientists use agents and models directly in their workflows, connected to structured data. The result: faster teams, better molecules, and breakthroughs for all. About Anthropic Anthropic is an AI research and development company that creates reliable, interpretable, and steerable AI systems. Anthropic's flagship product is Claude, a large language model trusted by millions of users worldwide. Anthropic's flagship product is Claude, a family of foundational AI models purpose-built for business tasks. Visit www.anthropic.com for more information. R&D use cases for Benchling AI in Claude Video - https://mma.prnasia.com/media2/2799822/Benchling_Anthropic_1080p.mp4 The information provided in this article was created by Cision PR Newswire, its news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Siam News Network.

AI tools for the modern lab. The future of scientific work is here with Benchling AI. Benchling is excited to introduce two exciting additions to the Benchling Platform: AI Agents and Models - designed to accelerate workflows, reduce toil, and unlock insights from your scientific data. Benchling Agents bring AI-powered support to every stage of research. With tools like the Data Entry Agent, Compose Agent, Ask Mode, and Deep Research Agent, scientists can document experiments, clean and organize legacy data, quickly find answers across notebooks and results, and generate comprehensive reports. Additional AI capabilities like SQL Writer and Notebook Check take this further by helping scientists save time on everyday tasks and ensure data quality. Together, Benchling Agents make it faster and easier to move science forward. While Benchling Agents help scientists capture and reason over their data, Benchling Models take the next step by helping them predict what comes next with predictive AI embedded directly into R&D workflows. Scientists can now access and run pre-trained models for tasks like protein structure prediction and binding affinity directly within Benchling, providing secure, real-time insights that connect seamlessly with your existing R&D data. Together, Benchling Agents and Models make AI a practical lab partner by helping scientists write, analyze, and interpret their work right where their data lives. Benchling Agents. Write up experiments in seconds, not hours, with the Compose Agent. The lab notebook of the future should free scientists from the burden of manually documenting everything they do. Meet the Compose Agent, Benchling's new chat-based agent that makes documenting experiments faster and easier than ever. With simple conversational inputs and uploaded files, scientists can instantly turn protocols, handwritten notes, or attachments into structured notebook entries and templates. * Organize experimental data * Extract information from uploaded notes * Draft a notebook entry for your experiment * Create a notebook template from an image of a protocol The goal is simple: free scientists from time-consuming documentation so they can focus on discovery. By automating one of the most common bottlenecks in the lab, the Compose Agent is an early glimpse into how Benchling AI is reshaping scientific work. Turn unstructured files into clean, usable data with the Data Entry Agent. The new Data Entry Agent streamlines one of science's most tedious tasks - converting messy, unstructured data into clean, structured information. Simply upload a PDF, Word document, or spreadsheet, and the agent goes to work, orchestrating a complex sequence of LLM calls to plan, process, and verify your data across multiple models. Built through months of iteration with customers, the Data Entry Agent transforms what once took hours of manual, error-prone work into a process that happens in minutes. By automatically extracting and structuring data from CoAs, legacy spreadsheets, and other sources, it frees scientists to focus on higher-value work like designing experiments and interpreting results. The result is less toil, faster workflows, and greater confidence in your data as the foundation for discovery. Ask mode - a faster, conversational way to explore your data. The new Ask mode lets scientists quickly get answers from their experiments, results, projects, and studies all in just 30 - 60 seconds. With a conversational interface, Ask extracts information from unstructured text, like Notebook entries or attachments, and combines it with structured data, including entities and results, to provide concise, citation-backed answers. Built as the default mode for Benchling AI, Ask is designed for speed and relevance, giving teams just the information they need to make decisions quickly. Need deeper insights or comprehensive reports? With a one-click toggle, Ask seamlessly transitions to Deep Research mode for more advanced exploration. Find insights and answer complex questions with the Deep Research Agent. Imagine being able to ask a question and instantly draw on years of experimental results, lab notebook entries, study reports, and scientific publications. The Deep Research Agent makes this possible by connecting information across your Benchling tenant and contextualizing it with public knowledge - all while keeping your proprietary data secure. Deep Research helps scientists validate findings, uncover hidden connections, and generate new ideas by surfacing insights grounded in the full context of past experiments. It acts less like a research assistant and more like a collaborative co-scientist, one that can reason across years of data and literature to help you inform what comes next. Here's how scientists are already using the Deep Research Agent to answer complex questions in minutes, rather than days: * Tracing experimental lineage of a protein, cell line, or viral vector - all in a single report that links to key experimental data * Synthesizing project updates with a single prompt, pulling from relevant notebook entries, requests, and more * Generating comprehensive reports that combine historical and current study data for review or collaboration In addition to its agents, Benchling offers a range of AI features across the platform that automate manual time-consuming busywork, making everyday scientific work faster and more efficient. SQL Writer lets scientists query complex data using plain language, turning data into insights without needing advanced SQL skills. Notebook Check reviews entries for completeness and accuracy, improving data quality and reducing human error. Together, these tools reduce manual effort and accelerate decision-making. Benchling Models give scientists a single, centralized place to connect experimental data with the world's most advanced scientific models. No more juggling external integrations or importing and exporting files. With seamless integration for structure prediction and molecular analysis, scientists can generate key insights, such as how a sequence might fold or behave and even compare results across multiple models, without ever leaving Benchling. Benchling Models bridge the gap between experimental and computational science, helping scientists create the medicines of tomorrow with cutting-edge molecular tools. Chai-1: A multi-modal foundation model for molecular structure prediction that performs at the state-of-the-art across a variety of benchmarks. Boltz-2: A biomolecular foundation model that jointly models complex structures and binding affinities. Try it out for yourself. Ready to see Benchling AI in action? Visit benchling.ai or enable it in your admin console. Start exploring today and see what AI can do for your lab. For customers: Details on how to activate Benchling AI, along with information on data protection and security, are available on the help page.